Mycobacterium vaccae for down-regulation of the Th2 activity of the immune system
AssigneeStanford Rook Limited
InventorsGraham A. Rook, John L. Stanford, Alimuddin L. Zumla
Life of this patent
Estimating the term…
Abstract
Antigenic and/or immunogenic material derived from Mycobacterium vaccae is used to down-regulate Th2 activity of the immune system without up-regulation of Th1 activity. Disorders such as Chronic Fatigue Syndrome, Gulf War Syndrome and Total Allergy Syndrome are treated. The material preferably comprises dead M. vaccae cells in a composition which does not include a non-M. vaccae antigen, immunogen or allergen.
Claims9
Use of antigenic and/or immunoregulatory material derived from Mycobacterium vaccae in the manufacture of a medicament, which medicament does not include any non-M. vaccae antigen, immunogen or allergen, for treatment of Chronic Fatigue Syndrome by down-regulation of Th2 activity of the immune system of an individual without up-regulation of Th1 activitv of the individual's immune system.
A composition comprising antigenic and/or immunoregulatory material derived from Mycobacterium vaccae and not any non-M. vaccae antigen, immunogen or allergen, for use in treatment or Chronic Fatigue Syndrome by down-regulation of Th2 activity of the immune system of an individual without up-regulation of Th1 activity of the individual's immune system.
A method of treating Chronic Fatigue Syndrome by down-regulating Th2 activity of the immune system of an individual without up-regulation of Th1 activity of the individual's immune system, the method comprising administering to the individual a composition comprising antigenic and/or immunoregulatory material derived from Mycobacterium vaccae and not any non-M. vaccae antigen, immunogen or allergen.
Dependencies are inferred from the claim text.